Nešić, Zorica I.

Link to this page

Authority KeyName Variants
0673cdc6-c5db-4045-a152-8e83b99cba35
  • Nešić, Zorica I. (2)
  • Nešić, Zorica (1)
Projects
No records found.

Author's Bibliography

Opioid analgesics [Opioidni analgetici.]

Vučković, Sonja M.; Prostran, Milica Š.; Ivanović, Milovan; Todorović, Zoran B.; Stojanović, Radan M.; Nešić, Zorica I.; Matić, Ivana; Milovanović, Slobodan R.

(2004)

TY  - JOUR
AU  - Vučković, Sonja M.
AU  - Prostran, Milica Š.
AU  - Ivanović, Milovan
AU  - Todorović, Zoran B.
AU  - Stojanović, Radan M.
AU  - Nešić, Zorica I.
AU  - Matić, Ivana
AU  - Milovanović, Slobodan R.
PY  - 2004
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/134
T2  - Vojnosanitetski pregled
T1  - Opioid analgesics [Opioidni analgetici.]
T1  - Opioidni analgetici
VL  - 61
IS  - 4
SP  - 413
EP  - 421
DO  - 10.2298/VSP0404413V
ER  - 
@article{
author = "Vučković, Sonja M. and Prostran, Milica Š. and Ivanović, Milovan and Todorović, Zoran B. and Stojanović, Radan M. and Nešić, Zorica I. and Matić, Ivana and Milovanović, Slobodan R.",
year = "2004",
journal = "Vojnosanitetski pregled",
title = "Opioid analgesics [Opioidni analgetici.], Opioidni analgetici",
volume = "61",
number = "4",
pages = "413-421",
doi = "10.2298/VSP0404413V"
}
Vučković, S. M., Prostran, M. Š., Ivanović, M., Todorović, Z. B., Stojanović, R. M., Nešić, Z. I., Matić, I.,& Milovanović, S. R.. (2004). Opioid analgesics [Opioidni analgetici.]. in Vojnosanitetski pregled, 61(4), 413-421.
https://doi.org/10.2298/VSP0404413V
Vučković SM, Prostran MŠ, Ivanović M, Todorović ZB, Stojanović RM, Nešić ZI, Matić I, Milovanović SR. Opioid analgesics [Opioidni analgetici.]. in Vojnosanitetski pregled. 2004;61(4):413-421.
doi:10.2298/VSP0404413V .
Vučković, Sonja M., Prostran, Milica Š., Ivanović, Milovan, Todorović, Zoran B., Stojanović, Radan M., Nešić, Zorica I., Matić, Ivana, Milovanović, Slobodan R., "Opioid analgesics [Opioidni analgetici.]" in Vojnosanitetski pregled, 61, no. 4 (2004):413-421,
https://doi.org/10.2298/VSP0404413V . .
1
1
1

Analgesic and hyperthermic effects of 3-carbomethoxy fentanyl and 3-butyl fentanyl in rats: Structure-activity relationship

Vučković, Sonja M.; Prostran, Milica Š.; Ivanović, Milovan; Todorović, Zoran B.; Stojanović, Radan M.; Nešić, Zorica I.

(2002)

TY  - CONF
AU  - Vučković, Sonja M.
AU  - Prostran, Milica Š.
AU  - Ivanović, Milovan
AU  - Todorović, Zoran B.
AU  - Stojanović, Radan M.
AU  - Nešić, Zorica I.
PY  - 2002
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/131
C3  - Arhiv za farmaciju
T1  - Analgesic and hyperthermic effects of 3-carbomethoxy fentanyl and 3-butyl fentanyl in rats: Structure-activity relationship
T1  - Analgetički i hipertermni efekti 3-karbometoksi fentanila u pacova: odnos strukture i farmakološke aktivnosti
VL  - 52
IS  - 4
SP  - 626
EP  - 627
UR  - https://hdl.handle.net/21.15107/rcub_cherry_131
ER  - 
@conference{
author = "Vučković, Sonja M. and Prostran, Milica Š. and Ivanović, Milovan and Todorović, Zoran B. and Stojanović, Radan M. and Nešić, Zorica I.",
year = "2002",
journal = "Arhiv za farmaciju",
title = "Analgesic and hyperthermic effects of 3-carbomethoxy fentanyl and 3-butyl fentanyl in rats: Structure-activity relationship, Analgetički i hipertermni efekti 3-karbometoksi fentanila u pacova: odnos strukture i farmakološke aktivnosti",
volume = "52",
number = "4",
pages = "626-627",
url = "https://hdl.handle.net/21.15107/rcub_cherry_131"
}
Vučković, S. M., Prostran, M. Š., Ivanović, M., Todorović, Z. B., Stojanović, R. M.,& Nešić, Z. I.. (2002). Analgesic and hyperthermic effects of 3-carbomethoxy fentanyl and 3-butyl fentanyl in rats: Structure-activity relationship. in Arhiv za farmaciju, 52(4), 626-627.
https://hdl.handle.net/21.15107/rcub_cherry_131
Vučković SM, Prostran MŠ, Ivanović M, Todorović ZB, Stojanović RM, Nešić ZI. Analgesic and hyperthermic effects of 3-carbomethoxy fentanyl and 3-butyl fentanyl in rats: Structure-activity relationship. in Arhiv za farmaciju. 2002;52(4):626-627.
https://hdl.handle.net/21.15107/rcub_cherry_131 .
Vučković, Sonja M., Prostran, Milica Š., Ivanović, Milovan, Todorović, Zoran B., Stojanović, Radan M., Nešić, Zorica I., "Analgesic and hyperthermic effects of 3-carbomethoxy fentanyl and 3-butyl fentanyl in rats: Structure-activity relationship" in Arhiv za farmaciju, 52, no. 4 (2002):626-627,
https://hdl.handle.net/21.15107/rcub_cherry_131 .

Opioid analgesics: Structure-activity study of the fentanyl analogues

Vučković, Sonja M.; Prostran, Milica; Ivanović, Milovan; Todorović, Zoran B.; Stojanović, Radan; Nešić, Zorica; Matić, Ivana

(2001)

TY  - JOUR
AU  - Vučković, Sonja M.
AU  - Prostran, Milica
AU  - Ivanović, Milovan
AU  - Todorović, Zoran B.
AU  - Stojanović, Radan
AU  - Nešić, Zorica
AU  - Matić, Ivana
PY  - 2001
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/139
AB  - Fentanyl, the prototype of the 4-anilidopiperidine class of synthetic opioid analgesics, is widely and successfully used to supplement general anesthesia or to treat postoperative and cancer pain. However, like other m agonists, fentanyl produces serious adverse effects including respiratory depression, muscle rigidity and on prolonged use, tolerance and addiction. In order to discover an analgesic with the improved pharmacodynamic and pharmacokinetic profile, extensive efforts during last four decades have been devoted to synthesis of a large number of fentanyl analogues and establishing the structure-activity-relationship (SAR) of the 4-anilidopiperidine class of analgesics. The objective of SAR studies is to approach the ideal analgesic profile focusing mainly on potency, safety and duration of action. As a result of such efforts, several congeners of fentanyl: alfentanil, sufentanil and remifentanil were discovered and have found clinical use as anesthesia adjuncts. Several other compounds are still under extensive evaluation in animals nowadays, while some of them are proposed as a useful tools in studying the opioid receptors. An interesting SAR obtained with some newly synthesized 3-alkyl fentanyl analogues, as well as 3-carbomethoxy fentanyl (iso-carfentanil) is presented and discussed in this paper. The analgesic potency of 3-carbomethoxy fentanyl is influenced mainly by the steric factor (voluminosity of the carbomethoxy group and the cis/trans isomerism), while the chemical nature of the group is probably irrelevant. In contrast to potency, the duration of action of 3-carbomethoxy fentanyl is most likely influenced by the nature of the carbomethoxy group. Since the potency and the duration of action of this novel analgesic compound are interesting from the aspect of SAR studies, and have potential promise for clinical use, 3-carbomethoxy fentanyl deserves to be extensively evaluated.
AB  - Fentanil, predstavnik grupe sintetičkih opioidnih analgetika (4-anilidopiperidina), ima široku primenu kao dodatak opštoj anesteziji, u terapiji postoperativnog bola, kao i bola uzrokovanog karcinomima. Medjutim, kao i drugi m agonisti opioidnih receptora, fentanil prouzrokuje ozbiljne neželjene efekate kao što su depresija disanja, rigiditet skeletne muskulature, a posle duže primene dolazi do pojave tolerancije i zavisnosti. Tokom poslednje četiri decenije uloženi su značajni napori da se sintetiše veliki broj analoga fentanila, kao i da se ustanovi odnos hemijske strukture i farmakološke aktivnosti (SAR) grupe analgetika koji pripadaju 4-anilidopiperidinima, a sve to u cilju pronalaženja analgetika sa boljim farmakodinamskim i farmakokinetičkim profilom dejstva. Cilj SAR studija je da se što više približimo profilu idealnog analgetika sa akcentom uglavnom na jačini, bezbednosti i dužini dejstva. Kao rezultat svih ovih napora, otkriveno je nekoliko jedinjenja srodnih fentanilu koji su našli kliničku primenu u anesteziji: alfentanil, sufentanil i remifentanil. U toku je detaljno ispitivanje nekoliko drugih jedinjenja u eksperimen­tima na životinjama, dok su neka od njih predložena kao korisni ligandi u receptorskim studijama. Interesantni rezultati dobijeni u SAR studijama sa nekoliko novosintetisanih 3-alkil analoga fentanila, kao i 3-karbometoksi fentanila (izo-karfentanila) prikazani su i diskutovani u ovom radu. Analgetička jačina 3-karbometoksi fentanila zavisi uglavnom od sternih faktora (voluminoznost karbometoksi grupe i cis/trans izomerija), dok je uticaj hemijske prirode same karbometoksi grupe verovatno nebitan. Za razliku od jačine, dužina trajanja dejstva 3-karbometoksi fentanila najverovatnije je uslovljena prirodom karbometoksi grupe. Budući da su jačina i dužina dejstva ove nove supstance sa analgetičkim dejstvom interesantni sa aspekta SAR studija, kao i da dosadašnji rezultati obećavaju da bi mogla potencijalno biti primenjivana u klinici, 3-karbometoksi fentanil zaslužuje opsežnije ispitivanje.
T2  - Engrami
T1  - Opioid analgesics: Structure-activity study of the fentanyl analogues
T1  - Opioidni analgetici - studija odnosa strukture i farmakološke aktivnosti analoga fentanila
VL  - 23
IS  - 3-4
SP  - 31
EP  - 49
UR  - https://hdl.handle.net/21.15107/rcub_cherry_139
ER  - 
@article{
author = "Vučković, Sonja M. and Prostran, Milica and Ivanović, Milovan and Todorović, Zoran B. and Stojanović, Radan and Nešić, Zorica and Matić, Ivana",
year = "2001",
abstract = "Fentanyl, the prototype of the 4-anilidopiperidine class of synthetic opioid analgesics, is widely and successfully used to supplement general anesthesia or to treat postoperative and cancer pain. However, like other m agonists, fentanyl produces serious adverse effects including respiratory depression, muscle rigidity and on prolonged use, tolerance and addiction. In order to discover an analgesic with the improved pharmacodynamic and pharmacokinetic profile, extensive efforts during last four decades have been devoted to synthesis of a large number of fentanyl analogues and establishing the structure-activity-relationship (SAR) of the 4-anilidopiperidine class of analgesics. The objective of SAR studies is to approach the ideal analgesic profile focusing mainly on potency, safety and duration of action. As a result of such efforts, several congeners of fentanyl: alfentanil, sufentanil and remifentanil were discovered and have found clinical use as anesthesia adjuncts. Several other compounds are still under extensive evaluation in animals nowadays, while some of them are proposed as a useful tools in studying the opioid receptors. An interesting SAR obtained with some newly synthesized 3-alkyl fentanyl analogues, as well as 3-carbomethoxy fentanyl (iso-carfentanil) is presented and discussed in this paper. The analgesic potency of 3-carbomethoxy fentanyl is influenced mainly by the steric factor (voluminosity of the carbomethoxy group and the cis/trans isomerism), while the chemical nature of the group is probably irrelevant. In contrast to potency, the duration of action of 3-carbomethoxy fentanyl is most likely influenced by the nature of the carbomethoxy group. Since the potency and the duration of action of this novel analgesic compound are interesting from the aspect of SAR studies, and have potential promise for clinical use, 3-carbomethoxy fentanyl deserves to be extensively evaluated., Fentanil, predstavnik grupe sintetičkih opioidnih analgetika (4-anilidopiperidina), ima široku primenu kao dodatak opštoj anesteziji, u terapiji postoperativnog bola, kao i bola uzrokovanog karcinomima. Medjutim, kao i drugi m agonisti opioidnih receptora, fentanil prouzrokuje ozbiljne neželjene efekate kao što su depresija disanja, rigiditet skeletne muskulature, a posle duže primene dolazi do pojave tolerancije i zavisnosti. Tokom poslednje četiri decenije uloženi su značajni napori da se sintetiše veliki broj analoga fentanila, kao i da se ustanovi odnos hemijske strukture i farmakološke aktivnosti (SAR) grupe analgetika koji pripadaju 4-anilidopiperidinima, a sve to u cilju pronalaženja analgetika sa boljim farmakodinamskim i farmakokinetičkim profilom dejstva. Cilj SAR studija je da se što više približimo profilu idealnog analgetika sa akcentom uglavnom na jačini, bezbednosti i dužini dejstva. Kao rezultat svih ovih napora, otkriveno je nekoliko jedinjenja srodnih fentanilu koji su našli kliničku primenu u anesteziji: alfentanil, sufentanil i remifentanil. U toku je detaljno ispitivanje nekoliko drugih jedinjenja u eksperimen­tima na životinjama, dok su neka od njih predložena kao korisni ligandi u receptorskim studijama. Interesantni rezultati dobijeni u SAR studijama sa nekoliko novosintetisanih 3-alkil analoga fentanila, kao i 3-karbometoksi fentanila (izo-karfentanila) prikazani su i diskutovani u ovom radu. Analgetička jačina 3-karbometoksi fentanila zavisi uglavnom od sternih faktora (voluminoznost karbometoksi grupe i cis/trans izomerija), dok je uticaj hemijske prirode same karbometoksi grupe verovatno nebitan. Za razliku od jačine, dužina trajanja dejstva 3-karbometoksi fentanila najverovatnije je uslovljena prirodom karbometoksi grupe. Budući da su jačina i dužina dejstva ove nove supstance sa analgetičkim dejstvom interesantni sa aspekta SAR studija, kao i da dosadašnji rezultati obećavaju da bi mogla potencijalno biti primenjivana u klinici, 3-karbometoksi fentanil zaslužuje opsežnije ispitivanje.",
journal = "Engrami",
title = "Opioid analgesics: Structure-activity study of the fentanyl analogues, Opioidni analgetici - studija odnosa strukture i farmakološke aktivnosti analoga fentanila",
volume = "23",
number = "3-4",
pages = "31-49",
url = "https://hdl.handle.net/21.15107/rcub_cherry_139"
}
Vučković, S. M., Prostran, M., Ivanović, M., Todorović, Z. B., Stojanović, R., Nešić, Z.,& Matić, I.. (2001). Opioid analgesics: Structure-activity study of the fentanyl analogues. in Engrami, 23(3-4), 31-49.
https://hdl.handle.net/21.15107/rcub_cherry_139
Vučković SM, Prostran M, Ivanović M, Todorović ZB, Stojanović R, Nešić Z, Matić I. Opioid analgesics: Structure-activity study of the fentanyl analogues. in Engrami. 2001;23(3-4):31-49.
https://hdl.handle.net/21.15107/rcub_cherry_139 .
Vučković, Sonja M., Prostran, Milica, Ivanović, Milovan, Todorović, Zoran B., Stojanović, Radan, Nešić, Zorica, Matić, Ivana, "Opioid analgesics: Structure-activity study of the fentanyl analogues" in Engrami, 23, no. 3-4 (2001):31-49,
https://hdl.handle.net/21.15107/rcub_cherry_139 .